TLC C-53 liposomal prostaglandin-E1 to prevent platelet aggregation: Began placebo-controlled Phase II trial in 100 patients in combination with tPA, heparin, a

The Liposome Co.

Read the full 36 word article

How to gain access

Continue reading with a
two-week free trial.